share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director YALE PHYLLIS R

SEC announcement ·  Apr 3 06:46
Summary by Futu AI
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb Co. [BMY], has engaged in a transaction involving the company's stock on March 31, 2024. The details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, have not been disclosed in the announcement. The relationship of Yale to the issuer was not specified, and the transaction's status, whether it was a purchase or sale, is also not provided in the available information.
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb Co. [BMY], has engaged in a transaction involving the company's stock on March 31, 2024. The details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, have not been disclosed in the announcement. The relationship of Yale to the issuer was not specified, and the transaction's status, whether it was a purchase or sale, is also not provided in the available information.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.